Your session is about to expire
← Back to Search
Active tDCS for Psychosis
Study Summary
This trial will study whether a noninvasive brain stimulation technique can improve cognitive remediation therapy for people with psychotic disorders.
- Psychosis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants still being accepted for this clinical experiment?
"Affirmative, the records on clinicaltrials.gov demonstrate that this research is searching for individuals to participate in their study. It was initially posted on March 14th 2019 and modified most recently November 14th 2022. This investigation requires 85 participants from a single medical facility."
Are individuals aged 50+ being accepted into the clinical trial?
"As outlined by the eligibility criteria, only patients between 18 and 64 years of age can enroll in this study. In contrast, 116 studies are available to those under eighteen while 262 are suitable for individuals over 65."
Would I be eligible to join this medical experiment?
"This experimental research necessitates 85 participants to be suffering from psychosis and aged between 18-64. To qualify, applicants must have an outpatience status of no less than one month before the study begins, been taking a constant dose of psychiatrics medication for at least 4 weeks prior to entry, and meet additional criteria."
How many participants are taking part in this trial at its maximum capacity?
"Affirmative. Per the information on clinicaltrials.gov, recruitment for this medical investigation is in full swing as of November 14th 2022; it was first posted March 14th 2019 and requires 85 patients from a single site to complete the study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger